| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1081-1206(10)61090-3 |
| P698 | PubMed publication ID | 17165269 |
| P50 | author | Nunzio Crimi | Q42521194 |
| Giovanni Passalacqua | Q61949008 | ||
| Franco Frati | Q92856617 | ||
| P2093 | author name string | Giorgio Walter Canonica | |
| Claudio Ortolani | |||
| Patrizia Berto | |||
| Gianenrico Senna | |||
| Italian SPAI Study Group | |||
| P2860 | cites work | Sublingual immunotherapy for allergic rhinitis | Q24248657 |
| Modelling in economic evaluation: an unavoidable fact of life | Q28243908 | ||
| Allergic rhinitis and its impact on asthma | Q34438438 | ||
| Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper | Q34754637 | ||
| Noninjection routes for immunotherapy | Q35087289 | ||
| Efficacy and safety of sublingual immunotherapy | Q35849524 | ||
| Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis | Q40523833 | ||
| Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. | Q40657964 | ||
| Ragweed immunotherapy in adult asthma | Q40672079 | ||
| Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more | Q45088211 | ||
| Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years | Q47795423 | ||
| Safety of sublingual immunotherapy in children with asthma. | Q51646876 | ||
| Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. | Q51686636 | ||
| Rhinitis as an independent risk factor for adult-onset asthma. | Q51723774 | ||
| Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany. | Q52972998 | ||
| Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. | Q54423199 | ||
| Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects☆☆☆★Results from the European Community Respiratory Health Survey | Q59556064 | ||
| Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking | Q74316536 | ||
| Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study | Q74566144 | ||
| Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years | Q81301079 | ||
| P433 | issue | 5 | |
| P921 | main subject | Italy | Q38 |
| immunotherapy | Q1427096 | ||
| pollen allergy | Q8194502 | ||
| P304 | page(s) | 615-621 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Annals of Allergy, Asthma & Immunology | Q13429696 |
| P1476 | title | Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study | |
| P478 | volume | 97 |
| Q36411170 | Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses |
| Q47149942 | Chinese Guideline on allergen immunotherapy for allergic rhinitis |
| Q51123060 | Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma. |
| Q34041905 | Development of a sublingual allergy vaccine for grass pollinosis |
| Q36791729 | Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults |
| Q33573199 | Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children |
| Q51137105 | Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma. |
| Q42657579 | Economic evaluation of sublingual vs subcutaneous allergen immunotherapy |
| Q40616842 | Is sublingual immunotherapy the final answer? Implications for the allergist |
| Q46015098 | Perception and practice of sublingual immunotherapy among practicing allergists. |
| Q57423287 | Response |
| Q34353492 | Specific immunotherapy by the sublingual route for respiratory allergy |
| Q36994648 | Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations |
Search more.